1.
Baseline characteristics of stent placement in intervention room and operating room.
| Variables | Intervention room (n=39) | Operating room (n=43) | P | ||
| No. | Percent | No. | Percent | ||
| *: Including chemotherapy, radiotherapy and palliative treatment; #: caused by airway neoplasm or extrinsic compression. | |||||
| Gender | 0.571 | ||||
| Male | 28 | 71.79% | 32 | 74.42% | |
| Female | 10 | 25.64% | 11 | 25.58% | |
| Age (yr) | 62.03±10.56 | 63.06±11.50 | 0.520 | ||
| Primary disease | 0.477 | ||||
| Lung cancer | 18 | 46.15% | 15 | 34.88% | |
| Esophageal cancer | 14 | 35.90% | 21 | 48.84% | |
| Others | 7 | 17.95% | 7 | 16.28% | |
| Drinking | 0.313 | ||||
| Yes | 19 | 48.72% | 23 | 53.49% | |
| No | 13 | 33.33% | 17 | 39.53% | |
| Unknown | 7 | 17.95% | 3 | 6.98% | |
| Smoking | 0.317 | ||||
| Yes | 16 | 41.03% | 20 | 46.51% | |
| No | 16 | 41.03% | 20 | 46.51% | |
| Unknown | 7 | 17.95% | 3 | 6.98% | |
| Charlson comorbidity index | 0.018 | ||||
| < 4 | 18 | 46.15% | 13 | 30.23% | |
| ≥5 | 14 | 35.90% | 28 | 65.12% | |
| Unknown | 7 | 17.95% | 2 | 4.65% | |
| Clinical manifestation | 0.815 | ||||
| Obstruction# | 27 | 69.23% | 28 | 65.12% | |
| Fistula | 12 | 30.77% | 15 | 34.88% | |
| Pre-stent therapy | 1.000 | ||||
| Surgery | 18 | 46.15% | 19 | 44.19% | |
| Others* | 21 | 53.85% | 24 | 55.81% | |
| Location | 0.066 | ||||
| Above the carina | 21 | 53.85% | 32 | 74.42% | |
| Below the carina | 18 | 46.15% | 11 | 25.58% | |
| Y-shaped stent | < 0.001 | ||||
| No | 34 | 87.18% | 9 | 20.93% | |
| Yes | 5 | 12.82% | 34 | 79.07% | |